1-99993575-C-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_012243.3(SLC35A3):āc.21C>Gā(p.Tyr7*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Synonymous variant affecting the same amino acid position (i.e. Y7Y) has been classified as Likely benign.
Frequency
Consequence
NM_012243.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC35A3 | NM_012243.3 | c.21C>G | p.Tyr7* | stop_gained | 2/8 | ENST00000533028.8 | NP_036375.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC35A3 | ENST00000533028.8 | c.21C>G | p.Tyr7* | stop_gained | 2/8 | 1 | NM_012243.3 | ENSP00000433849.1 | ||
ENSG00000283761 | ENST00000639037.1 | c.21C>G | p.Tyr7* | stop_gained | 2/17 | 5 | ENSP00000492745.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251276Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135812
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461642Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727124
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 12, 2022 | The c.21C>G (p.Y7*) alteration, located in exon 2 (coding exon 1) of the SLC35A3 gene, consists of a C to G substitution at nucleotide position 21. This changes the amino acid from a tyrosine (Y) to a stop codon at amino acid position 7. The predicted stop codon occurs in the 5' end of the SLC35A3 gene. Premature termination codons in the 5’ end of a gene have been reported to escape nonsense-mediated mRNA decay and/or lead to re-initiation (Rivas, 2015; Lindeboom, 2016; Rhee, 2017). Direct evidence for this alteration is unavailable; however, premature termination codons are typically deleterious in nature. Based on data from gnomAD, the G allele has an overall frequency of <0.01% (5/251276) total alleles studied. The highest observed frequency was 0.01% (5/34564) of Latino alleles. Based on the available evidence, this alteration is classified as likely pathogenic. - |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1433891). This variant has not been reported in the literature in individuals affected with SLC35A3-related conditions. This variant is present in population databases (rs775151826, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Tyr7*) in the SLC35A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC35A3 are known to be pathogenic (PMID: 24031089, 28328131). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at